http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106699894-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-10 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 |
filingDate | 2016-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-106699894-B |
titleOfInvention | Application of human Sec5 protein |
abstract | The invention proves that the IP3R3 type is combined with human Sec5 protein through a co-immunoprecipitation experiment, and proves that the human Sec5 protein-2 segment and the human Sec5 protein-4 segment are combined with the H1 segment of the IP3R1 through a Pull down experiment, and proves that the human Sec5-2 segment has a promoting effect on the phagocytosis function of RAW264.7 cells; on the basis, the invention discloses the application of human Sec5 protein and human Sec5 protein-2 fragment in the preparation of antifungal infection resisting drugs, and has good development and application prospects in the field of anti-infective drugs. |
priorityDate | 2016-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 789.